Gemcitabine plus cisplatin versus fluorouracil plus cisplatin in recurrent or metastatic nasopharyngeal carcinoma: a multicentre, randomised, open-label, phase 3 trial

Li Zhang, Yan Huang, Shaodong Hong, +25

The Lancet

Cisplatin Versus FluorouracilMedicineMetronomic TherapyPathologyCancer Treatment +4

KRAS mutation-induced upregulation of PD-L1 mediates immune escape in human lung adenocarcinoma

Nan Chen, Wenfeng Fang, Lin Zhong, +11

Cancer Immunology Immunotherapy

The association between PD-L1 and EGFR status and the prognostic value of PD-L1 in advanced non-small cell lung cancer patients treated with EGFR-TKIs

Yanna Tang, Wenfeng Fang, Yaxiong Zhang, +11

Oncotarget

Gemcitabine Plus Cisplatin Versus Fluorouracil Plus Cisplatin as First-Line Therapy for Recurrent or Metastatic Nasopharyngeal Carcinoma: Final Overall Survival Analysis of GEM20110714 Phase III Study

Shaodong Hong, Yaxiong Zhang, Gengsheng Yu, +27

Journal of Clinical Oncology

Low Prognostic Nutritional Index (PNI) Predicts Unfavorable Distant Metastasis-Free Survival in Nasopharyngeal Carcinoma: A Propensity Score-Matched Analysis

Lin Yang, Liangping Xia, Yan Wang, +5

PLoS ONE

Development and External Validation of Nomograms for Predicting Survival in Nasopharyngeal Carcinoma Patients after Definitive Radiotherapy

Lin Yang, Shaodong Hong, Yan Wang, +4

Scientific Reports

Perineural Invasion and TAMs in Pancreatic Ductal Adenocarcinomas: Review of the Original Pathology Reports Using Immunohistochemical Enhancement and Relationships with Clinicopathological Features

Linjuan Zeng, Yubo Guo, Jianzhong Liang, +6

Journal of Cancer

EGFR Oncogenic Mutations in NSCLC Impair Macrophage Phagocytosis and Mediate Innate Immune Evasion Through Up-Regulation of CD47

Liyang Hu, Weitao Zhuang, Mao-jian Chen, +12

Journal of Thoracic Oncology

InflammationEgfr Oncogenic MutationsImmune Cell DevelopmentInnate Immune SystemImmunology +5

Multicenter phase II study of capecitabine combined with nedaplatin for recurrent and metastatic nasopharyngeal carcinoma patients after failure of cisplatin-based chemotherapy

Peijian Peng, Xue‐Qing Ou, Zhibin Chen, +5

Cancer Chemotherapy and Pharmacology

OncologyCisplatin-based ChemotherapyMedicineAnti-cancer AgentCancer Treatment +3

Association between PD-L1 Expression on Tumour-Infiltrating Lymphocytes and Overall Survival in Patients with Gastric Cancer

Wenfeng Fang, Ying Chen, Sheng Jin, +7

Journal of Cancer